HOME >> BIOLOGY >> NEWS
Talking robots, green buildings, and shockwave healing

Melville, New York, April 12, 2005---Do students change their accents shortly after they enroll in college? How can ultrasound trigger healing in bone fractures that are otherwise very stubborn to mend? Could airplane noise lower a student's test scores?

These and other questions will be addressed at the joint meeting of the Acoustical Society of America (ASA) and the Canadian Acoustical Association (CAA), to be held May 16-20, 2005 at the Hyatt Regency Vancouver Hotel (655 Burrard Street, Vancouver, BC V6C 2R7, Canada, 604-639-4820). Over 1050 papers will be presented, making it one of the largest acoustics meetings to date. ASA (http://asa.aip.org) is the largest scientific organization in the United States devoted to acoustics. CAA (http://www.caa-aca.ca) is a professional, interdisciplinary organization devoted to acoustics in Canada.

WORLD WIDE PRESS ROOM

We encourage you to visit ASA's "World Wide Press Room" (located at http://www.acoustics.org/press) before and during the meeting. By the week of May 2, the site will contain lay-language versions of selected meeting papers. These papers will enable you to cover the meeting, even if you can't leave your desk.

MEDIA INQUIRIES

Reporters covering the meeting can receive a complimentary press badge to attend all sessions. Please fill out the reply form if you are interested in attending the meeting. Ben Stein (bstein@aip.org, 301-209-3091) and Martha Heil (mheil@aip.org; 626-354-5613) of the American Institute of Physics will be available both remotely and on-site to facilitate your requests, from contacting speakers at the meeting to obtaining background material on meeting topics.

VIEWING MEETING ABSTRACTS

Full abstracts of the papers mentioned in this
'"/>

Contact: Ben Stein
bstein@aip.org
301-209-3091
American Institute of Physics
12-Apr-2005


Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology news :

1. Climate change and permafrost thaw alter greenhouse gas emissions in northern wetlands
2. Clues to future evolution of HIV come from African green monkeys
3. Citrus greening continues to spread in citrus growing areas
4. Tomorrows green nanofactories
5. NIST building software offers green product advice
6. Nanotechnology provides green path to environmentally sustainable economy
7. NASA predicts nongreen plants on other planets
8. Building green made easier with new roadmap
9. New Geisinger Health System building green Center for Health Research
10. Its not easy being green
11. Its not easy being green

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Talking robots green buildings and shockwave healing

(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/14/2015)... 2015  HYPR Corp. today announced it has ... Alliance tm , an industry consortium transforming online ... share technology and collaborate to deliver open specifications ... secure and private, and easier to use. ... protects sensitive user information and eliminates the dependency ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... W. R. Grace & Co. (NYSE: ... Germany has received good manufacturing practice (GMP) certification ... Pharmaceutical Excipient Council (IPEC) Foundation. , ... FP brand of pharmaceutical grade excipient silica gels ... Bay, Maryland (USA) and Sorocaba, Brazil locations. The ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... May 20, 2015 Research and Markets ... of the "2015 Global Survey on Flow ... The primary goal of this research ... instruments and reagents. Key information the survey seeks ... of flow cytometers, predominantly used applications for flow ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: